- Filed
- Mar 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Feb 28, 2025 | 58.44M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 42.89M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 44.98M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2024 | $992K |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $980K |
| Dividends Paid | Q1 2024 · Mar 31, 2024 | $466K |
| Dividends Paid | Q1 2024 · Mar 31, 2023 | $252K |
| Capex | Q1 2024 · Mar 31, 2024 | $1.56M |
| Capex | Q1 2024 · Mar 31, 2023 | $1.82M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$522K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$6.66M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $16.79M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $20.78M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $165.62M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $176.64M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | $192.36M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | $198.51M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $29.63M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $28.99M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $46.25M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $46.46M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $124.06M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $127.66M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $225.07M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $236.3M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.23 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.11 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.23 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.11 |
| Net Income | Q1 2024 · Mar 31, 2024 | −$9.57M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$4.92M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$10.93M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$9M |